Treatable traits for long COVID
Respirology · 2023
DOI: 10.1111/resp.14596 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Respirology, 2023. Verfasst von Hayley Lewthwaite und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Research Excellence Treatable Traits, College of Health, Medicine, and Wellbeing, University of Newcastle, Newcastle, New South Wales, Aust…. Hauptthemen laut MEDLINE: Post-Acute COVID-19 Syndrome, COVID-19. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Long COVID, or post‐acute COVID‐19 sequelae, is experienced by an estimated one in eight adults following acute COVID‐19. Long COVID is a new and complex chronic health condition that typically includes multiple symptoms that cross organ systems and fluctuate over time; a one‐size‐fits‐all approach is, therefore, not likely to be appropriate nor relevant for long COVID treatment. ‘Treatable Traits’ is a personalized medicine approach, purpose‐built to address the complexity and heterogeneity of complex chronic conditions. This comprehensive review aimed to understand how a treatable traits approach could be applied to long COVID, by first identifying the most prevalent long COVID treatable traits and then the available evidence for strategies to target these traits. An umbrella review of 22 systematic reviews identified 34 symptoms and complications common with long COVID, grouped into eight long COVID treatable trait clusters: neurological, chest, psychological, pain, fatigue, sleep impairment, functional impairment and other. A systematic review of randomized control trials identified 18 studies that explored different intervention approaches for long COVID prevention ( k = 4) or management ( k = 14). While a single study reported metformin as effective for long COVID prevention, the findings need to be replicated and consensus is required around how to define long COVID as a clinical trial endpoint. For long COVID management, current evidence supports exercise training or respiratory muscle training for long COVID treatable traits in the chest and functional limitation clusters. While there are studies exploring interventions targeting other long COVID treatable traits, further high‐quality RCTs are needed, particularly targeting treatable traits in the clusters of fatigue, psychological, pain and sleep impairment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre of Research Excellence Treatable Traits, College of Health, Medicine, and Wellbeing, University of Newcastle, Newcastle, New South Wales, Australia.
- Asthma and Breathing Research Program, Hunter Medical Research Institute, Newcastle, New South Wales, Australia.
- Heart Lung Clinic, Department of Thoracic Medicine St Vincent's Hospital and Clinical School University of New South Wales, Darlinghurst, New South Wales, Australia.
- Peter Duncan Neuroscience Research Unit, St. Vincent's Centre for Applied Medical Research, Darlinghurst, New South Wales, Australia.
- Department of Neurology and Immunology, St. Vincent's Hospital, Darlinghurst, New South Wales, Australia.
- Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
ORCID-Profile: Hayley Lewthwaite, Peter G Gibson
Zitieren
APA
Lewthwaite, H., Byrne, A., Brew, B., & Gibson, P. G. (2023). Treatable traits for long COVID. Respirology. https://doi.org/10.1111/resp.14596
Vancouver
Lewthwaite H, Byrne A, Brew B, Gibson PG. Treatable traits for long COVID. Respirology. 2023. doi:10.1111/resp.14596
BibTeX
@article{Lewthwaite2023,
author = {Lewthwaite, Hayley and Byrne, Anthony and Brew, Bruce and Gibson, Peter G},
title = {Treatable traits for long COVID},
journal = {Respirology},
year = {2023},
doi = {10.1111/resp.14596}
}
EUVIMED